Universe Pharmaceuticals (UPC) EBITDA (2019 - 2025)
Universe Pharmaceuticals (UPC) EBITDA from Sep 30, 2019 to Sep 30, 2025. The TTM Universe Pharmaceuticals (UPC) EBITDA is -$2.40B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Universe Pharmaceuticals (UPC) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -68.16% |
| 3 Years | +617.63% |
Annual EBITDA change of Universe Pharmaceuticals (UPC)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$2.40B | -68.16% |
| 2024 | -$7.53B | +115987.98% |
| 2022 | -$6.49M | -146.23% |
| 2021 | $14M | +31.71% |
| 2020 | $11M | +4.82% |
| 2019 | $10M | N/A |